Kenneth Dipietro - Net Worth and Insider Trading
Kenneth Dipietro Net Worth
The estimated net worth of Kenneth Dipietro is at least $1 Million dollars as of 2024-11-06. Kenneth Dipietro is the Chief Human Resources Officer of Cerevel Therapeutics Holdings Inc and owns about 24,663 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $1 Million. Kenneth Dipietro is also the EVP Human Resources of Biogen Inc and owns about 0 shares of Biogen Inc (BIIB) stock worth over $0. Details can be seen in Kenneth Dipietro's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Dipietro has not made any transactions after 2023-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Dipietro
Kenneth Dipietro Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Dipietro owns 3 companies in total, including InVivo Therapeutics Holdings Corp (NVIVQ) , Biogen Inc (BIIB) , and Cerevel Therapeutics Holdings Inc (CERE) .
Click here to see the complete history of Kenneth Dipietro’s form 4 insider trades.
Insider Ownership Summary of Kenneth Dipietro
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVIVQ | InVivo Therapeutics Holdings Corp | 2014-12-10 | director |
| BIIB | Biogen Inc | 2015-03-16 | EVP Human Resources |
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-22 | Chief Human Resources Officer |
Kenneth Dipietro Latest Holdings Summary
Kenneth Dipietro currently owns a total of 2 stocks. Among these stocks, Kenneth Dipietro owns 24,663 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 22, 2023, with a value of $1 Million and a weighting of 100%. Kenneth Dipietro also owns 0 shares of Biogen Inc (BIIB) as of March 16, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of Kenneth Dipietro
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-22 | 24,663 | 44.96 | 1,108,848 |
| BIIB | Biogen Inc | 2015-03-16 | 0 | 176.93 | 0 |
Holding Weightings of Kenneth Dipietro
Kenneth Dipietro Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Dipietro has made a total of 2 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 8,000 shares on December 22, 2023, which brought Kenneth Dipietro around $331,600.
According to the SEC Form 4 filings, Kenneth Dipietro has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 803 shares on March 16, 2015, which brought Kenneth Dipietro around $333,614.
Insider Trading History of Kenneth Dipietro
- 1
Kenneth Dipietro Trading Performance
Kenneth Dipietro Ownership Network
Ownership Network List of Kenneth Dipietro
Ownership Network Relation of Kenneth Dipietro
Kenneth Dipietro Owned Company Details
What does InVivo Therapeutics Holdings Corp do?
Who are the key executives at InVivo Therapeutics Holdings Corp?
Kenneth Dipietro is the director of InVivo Therapeutics Holdings Corp. Other key executives at InVivo Therapeutics Holdings Corp include 10 percent owner Brice Foose , Chief Financial Officer Richard Christopher , and director & CEO and CMO Richard M. Toselli .
InVivo Therapeutics Holdings Corp (NVIVQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InVivo Therapeutics Holdings Corp (NVIVQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
InVivo Therapeutics Holdings Corp (NVIVQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
InVivo Therapeutics Holdings Corp Insider Transactions
Kenneth Dipietro Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Dipietro. You might contact Kenneth Dipietro via mailing address: C/o Biogen Idec Inc., 133 Boston Post Road, Weston Ma 02493.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
